Copyright Reports & Markets. All rights reserved.

Global Amino Acid Metabolism Disorders Treatment Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Amino Acid Metabolism Disorders Treatment

      • 1.1 Definition of Amino Acid Metabolism Disorders Treatment
      • 1.2 Amino Acid Metabolism Disorders Treatment Segment by Type
        • 1.2.1 Global Amino Acid Metabolism Disorders Treatment Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Arginine
        • 1.2.3 Folic Acid
        • 1.2.4 Vitamin B6 & B12
        • 1.2.5 Thiamine
        • 1.2.6 Vitamin D
        • 1.2.7 Betaine
        • 1.2.8 Carglumic Acid
        • 1.2.9 Saproterin Dihydrochloride
        • 1.2.10 Others
      • 1.3 Amino Acid Metabolism Disorders Treatment Segment by Applications
        • 1.3.1 Global Amino Acid Metabolism Disorders Treatment Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Phenylketonuria
        • 1.3.3 Maple Syrup Urine Disease
        • 1.3.4 Argininosuccinic Acidemia
        • 1.3.5 Citrullinemia
        • 1.3.6 Homocystinuria
      • 1.4 Global Amino Acid Metabolism Disorders Treatment Overall Market
        • 1.4.1 Global Amino Acid Metabolism Disorders Treatment Revenue (2014-2025)
        • 1.4.2 Global Amino Acid Metabolism Disorders Treatment Production (2014-2025)
        • 1.4.3 North America Amino Acid Metabolism Disorders Treatment Status and Prospect (2014-2025)
        • 1.4.4 Europe Amino Acid Metabolism Disorders Treatment Status and Prospect (2014-2025)
        • 1.4.5 China Amino Acid Metabolism Disorders Treatment Status and Prospect (2014-2025)
        • 1.4.6 Japan Amino Acid Metabolism Disorders Treatment Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Amino Acid Metabolism Disorders Treatment Status and Prospect (2014-2025)
        • 1.4.8 India Amino Acid Metabolism Disorders Treatment Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Amino Acid Metabolism Disorders Treatment
      • 2.3 Manufacturing Process Analysis of Amino Acid Metabolism Disorders Treatment
      • 2.4 Industry Chain Structure of Amino Acid Metabolism Disorders Treatment

      3 Development and Manufacturing Plants Analysis of Amino Acid Metabolism Disorders Treatment

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Amino Acid Metabolism Disorders Treatment Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Amino Acid Metabolism Disorders Treatment
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Amino Acid Metabolism Disorders Treatment Production and Capacity Analysis
      • 4.2 Amino Acid Metabolism Disorders Treatment Revenue Analysis
      • 4.3 Amino Acid Metabolism Disorders Treatment Price Analysis
      • 4.4 Market Concentration Degree

      5 Amino Acid Metabolism Disorders Treatment Regional Market Analysis

      • 5.1 Amino Acid Metabolism Disorders Treatment Production by Regions
        • 5.1.1 Global Amino Acid Metabolism Disorders Treatment Production by Regions
        • 5.1.2 Global Amino Acid Metabolism Disorders Treatment Revenue by Regions
      • 5.2 Amino Acid Metabolism Disorders Treatment Consumption by Regions
      • 5.3 North America Amino Acid Metabolism Disorders Treatment Market Analysis
        • 5.3.1 North America Amino Acid Metabolism Disorders Treatment Production
        • 5.3.2 North America Amino Acid Metabolism Disorders Treatment Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Amino Acid Metabolism Disorders Treatment Import and Export
      • 5.4 Europe Amino Acid Metabolism Disorders Treatment Market Analysis
        • 5.4.1 Europe Amino Acid Metabolism Disorders Treatment Production
        • 5.4.2 Europe Amino Acid Metabolism Disorders Treatment Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Amino Acid Metabolism Disorders Treatment Import and Export
      • 5.5 China Amino Acid Metabolism Disorders Treatment Market Analysis
        • 5.5.1 China Amino Acid Metabolism Disorders Treatment Production
        • 5.5.2 China Amino Acid Metabolism Disorders Treatment Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Amino Acid Metabolism Disorders Treatment Import and Export
      • 5.6 Japan Amino Acid Metabolism Disorders Treatment Market Analysis
        • 5.6.1 Japan Amino Acid Metabolism Disorders Treatment Production
        • 5.6.2 Japan Amino Acid Metabolism Disorders Treatment Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Amino Acid Metabolism Disorders Treatment Import and Export
      • 5.7 Southeast Asia Amino Acid Metabolism Disorders Treatment Market Analysis
        • 5.7.1 Southeast Asia Amino Acid Metabolism Disorders Treatment Production
        • 5.7.2 Southeast Asia Amino Acid Metabolism Disorders Treatment Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Amino Acid Metabolism Disorders Treatment Import and Export
      • 5.8 India Amino Acid Metabolism Disorders Treatment Market Analysis
        • 5.8.1 India Amino Acid Metabolism Disorders Treatment Production
        • 5.8.2 India Amino Acid Metabolism Disorders Treatment Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Amino Acid Metabolism Disorders Treatment Import and Export

      6 Amino Acid Metabolism Disorders Treatment Segment Market Analysis (by Type)

      • 6.1 Global Amino Acid Metabolism Disorders Treatment Production by Type
      • 6.2 Global Amino Acid Metabolism Disorders Treatment Revenue by Type
      • 6.3 Amino Acid Metabolism Disorders Treatment Price by Type

      7 Amino Acid Metabolism Disorders Treatment Segment Market Analysis (by Application)

      • 7.1 Global Amino Acid Metabolism Disorders Treatment Consumption by Application
      • 7.2 Global Amino Acid Metabolism Disorders Treatment Consumption Market Share by Application (2014-2019)

      8 Amino Acid Metabolism Disorders Treatment Major Manufacturers Analysis

      • 8.1 GlaxoSmithKline
        • 8.1.1 GlaxoSmithKline Amino Acid Metabolism Disorders Treatment Production Sites and Area Served
        • 8.1.2 GlaxoSmithKline Product Introduction, Application and Specification
        • 8.1.3 GlaxoSmithKline Amino Acid Metabolism Disorders Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Pfizer
        • 8.2.1 Pfizer Amino Acid Metabolism Disorders Treatment Production Sites and Area Served
        • 8.2.2 Pfizer Product Introduction, Application and Specification
        • 8.2.3 Pfizer Amino Acid Metabolism Disorders Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 AMINO
        • 8.3.1 AMINO Amino Acid Metabolism Disorders Treatment Production Sites and Area Served
        • 8.3.2 AMINO Product Introduction, Application and Specification
        • 8.3.3 AMINO Amino Acid Metabolism Disorders Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Merck
        • 8.4.1 Merck Amino Acid Metabolism Disorders Treatment Production Sites and Area Served
        • 8.4.2 Merck Product Introduction, Application and Specification
        • 8.4.3 Merck Amino Acid Metabolism Disorders Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Recordati
        • 8.5.1 Recordati Amino Acid Metabolism Disorders Treatment Production Sites and Area Served
        • 8.5.2 Recordati Product Introduction, Application and Specification
        • 8.5.3 Recordati Amino Acid Metabolism Disorders Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Koninklijke
        • 8.6.1 Koninklijke Amino Acid Metabolism Disorders Treatment Production Sites and Area Served
        • 8.6.2 Koninklijke Product Introduction, Application and Specification
        • 8.6.3 Koninklijke Amino Acid Metabolism Disorders Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Sanofi
        • 8.7.1 Sanofi Amino Acid Metabolism Disorders Treatment Production Sites and Area Served
        • 8.7.2 Sanofi Product Introduction, Application and Specification
        • 8.7.3 Sanofi Amino Acid Metabolism Disorders Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Shine Star (Hubei) Biological Engineering
        • 8.8.1 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorders Treatment Production Sites and Area Served
        • 8.8.2 Shine Star (Hubei) Biological Engineering Product Introduction, Application and Specification
        • 8.8.3 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorders Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Kyowa Hakko Kirin
        • 8.9.1 Kyowa Hakko Kirin Amino Acid Metabolism Disorders Treatment Production Sites and Area Served
        • 8.9.2 Kyowa Hakko Kirin Product Introduction, Application and Specification
        • 8.9.3 Kyowa Hakko Kirin Amino Acid Metabolism Disorders Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served

      9 Development Trend of Analysis of Amino Acid Metabolism Disorders Treatment Market

      • 9.1 Global Amino Acid Metabolism Disorders Treatment Market Trend Analysis
        • 9.1.1 Global Amino Acid Metabolism Disorders Treatment Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Amino Acid Metabolism Disorders Treatment Regional Market Trend
        • 9.2.1 North America Amino Acid Metabolism Disorders Treatment Forecast 2019-2025
        • 9.2.2 Europe Amino Acid Metabolism Disorders Treatment Forecast 2019-2025
        • 9.2.3 China Amino Acid Metabolism Disorders Treatment Forecast 2019-2025
        • 9.2.4 Japan Amino Acid Metabolism Disorders Treatment Forecast 2019-2025
        • 9.2.5 Southeast Asia Amino Acid Metabolism Disorders Treatment Forecast 2019-2025
        • 9.2.6 India Amino Acid Metabolism Disorders Treatment Forecast 2019-2025
      • 9.3 Amino Acid Metabolism Disorders Treatment Market Trend (Product Type)
      • 9.4 Amino Acid Metabolism Disorders Treatment Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Amino Acid Metabolism Disorders Treatment Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The key elements of an amino acid are carbon (C), hydrogen (H), oxygen (O), and nitrogen (N), although other elements are found in the side chains of certain amino acids. Some amino acids derivatives are used in pharmaceutical industry. They include 5-HTP (5-hydroxytryptophan) used for experimental treatment of depression, L-DOPA (L-dihydroxyphenylalanine) for Parkinson's treatment, and eflornithine drug that inhibits ornithine decarboxylase and used in the treatment of sleeping sickness. A metabolic disorder can happen when abnormal chemical reactions in the body alter the normal metabolic process. It can also be defined as inherited single gene anomaly, most of which are autosomal recessive.
        In the global market, North America is projected to retain a leading position in the market by the end of 2025 reaching a valuation of over US$359 Mn. It is expected to be closely followed by Europe.

        The global Amino Acid Metabolism Disorders Treatment market was valued at 750 million US$ in 2018 and will reach 1160 million US$ by the end of 2025, growing at a CAGR of 5.6% during 2019-2025.
        This report focuses on Amino Acid Metabolism Disorders Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Amino Acid Metabolism Disorders Treatment market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Amino Acid Metabolism Disorders Treatment in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Amino Acid Metabolism Disorders Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        GlaxoSmithKline
        Pfizer
        AMINO
        Merck
        Recordati
        Koninklijke
        Sanofi
        Shine Star (Hubei) Biological Engineering
        Kyowa Hakko Kirin

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Arginine
        Folic Acid
        Vitamin B6 & B12
        Thiamine
        Vitamin D
        Betaine
        Carglumic Acid
        Saproterin Dihydrochloride
        Others

        Segment by Application
        Phenylketonuria
        Maple Syrup Urine Disease
        Argininosuccinic Acidemia
        Citrullinemia
        Homocystinuria

        Buy now